VRM
DXCM icon

Vectors Research Management’s DexCom DXCM Stock Holding History

Vectors Research Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,422
Closed -$1.72M – 131
2024
Q1 		$1.72M Sell
12,422
-791
-6% -$99.4K 0.49% 54
2023
Q4 		$1.64M Sell
13,213
-113
-0.8% -$11.5K 0.46% 61
2023
Q3 		$1.16M Sell
13,326
-257
-2% -$29K 0.38% 66
2023
Q2 		$1.75M Sell
13,583
-1,172
-8% -$142K 0.5% 57
2023
Q1 		$1.71M Sell
14,755
-214
-1% -$24K 0.44% 58
2022
Q4 		$1.7M Sell
14,969
-1,867
-11% -$205K 0.44% 60
2022
Q3 		$1.36M Sell
16,836
-186
-1% -$15.8K 0.38% 65
2022
Q2 		$1.27M Sell
17,022
-346
-2% -$31.6K 0.32% 73
2022
Q1 		$2.22M Buy
17,368
+1,096
+7% +$120K 0.49% 48
2021
Q4 		$2.18M Buy
16,272
+388
+2% +$55.8K 0.46% 54
2021
Q3 		$2.17M Buy
15,884
+792
+5% +$99.9K 0.51% 49
2021
Q2 		$1.61M Buy
15,092
+780
+5% +$74.9K 0.41% 54
2021
Q1 		$1.29M Buy
14,312
+1,436
+11% +$135K 0.35% 65
2020
Q4 		$1.19M Buy
12,876
+3,712
+41% +$331K 0.37% 64
2020
Q3 		$940K Buy
9,164
+1,404
+18% +$147K 0.34% 70
2020
Q2 		$786K Buy
7,760
+64
+0.8% +$5.72K 0.31% 66
2020
Q1 		$518K Buy
7,696
+7,596
+7,596% +$473K 0.25% 71
2019
Q4 		$5K Hold
100
– – ﹤0.01% 415
2019
Q3 		$4K Hold
100
– – ﹤0.01% 365
2019
Q2 		$4K Buy
+100
New +$3.14K ﹤0.01% 332

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vectors Research Management's DXCM Position: Q2 2024 in Review

Vectors Research Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 12,422 shares — an estimated $1.72M sold.

Vectors Research Management first reported a position in DXCM in Q2 2019 and held it in 20 quarters. The position peaked at $2.22M in Q1 2022. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Vectors Research Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Vectors Research Management sold 12,422 DexCom shares in Q2 2024, an estimated $1.72M.
  • Vectors Research Management first reported a position in DexCom in Q2 2019 and held it in 20 quarters.
  • Vectors Research Management's DexCom position peaked at $2.22M in Q1 2022.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Vectors Research Management's 13F filing for Q2 2024, filed 9 Aug 2024.